Back to HSCSWView full pipeline
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Post Stroke Depression
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Regulatory Approvals
EMAPending
Zurzuvae
Zurzuvae is indicated for the treatment of postpartum depression (PPD) in adults following childbirth (see section 5.1).
View on EMADrug Science
Mechanism of action & safety profile
Related Pipeline
Ferric Derisomaltose 1000 Mg in 100 mL INTRAVENOUS SOLUTION [Monoferric]Phase 3
Iron-deficiency
Sacubitril-Valsartan 49 Mg-51 Mg Oral TabletPhase 3
Obesity
Mono-Therapy with SildenafilPhase 3
Pediatric Pulmonary Hypertension
Convalescent PlasmaPhase 3
Covid19
FosinoprilPhase 3
Microalbuminuria
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts